Financial Report

Net sales Operating profit
Net sales Operating income
Profit attributable to owners of patent Operating profit margin
Ordinary profit margin
Net profit margin
Ordinary profit Net income attributable to owners of the parent
Overseas sales/Overseas sales ratio Capital expenditures
Depreciation and amortization
Research and development expenses
Operating income/Net sales, Ordinary profit/Net sales, Net profit margin Capital expenditures/Depreciation/R&D expenses



Key Financial Data (Last Five Years, Consolidated)

FY2021 FY2022 FY2023 FY2024 FY2025
Net sales
(Millions of yen)
 9,852 10,928 11,539 11,804 13,629
Operating profit
(Millions of yen)
 -859 55 139 144 588
Operating profit margin
（%）
 -8.7 0.5 1.2 1.2 4.3
Ordinary profit
(Millions of yen)
 -685 211 204 212 679
Ordinary profit margin
（%）
 -7.0 1.9 1.8 1.8 5.0
Profit attributable to owners of patent
(Millions of yen)
 -1,271 246 438 1,459 395
Net profit margin
（%）
 -12.9 2.3 3.8 12.4 2.9
Overseas sales
(Millions of yen)
 1,415 1,808 2,125 1,911 2,321
Overseas sales ratio
（%）
 14.4 16.5 18.4 16.2 17.0
Total assets
(Millions of yen)
 19,446 21,109 21,003 21,309 21,783
Net assets
(Millions of yen)
 12,720 13,386 14,110 15,914 16,603
Equity-to asset ratio
（%）
 64.1 62.0 65.8 73.3 74.5
Rate of return on equity
（%）
 - 1.9 3.3 9.9 2.5
Earnings per Share
(EPS, yen)
 -114.67 23.82 41.68 138.77 38.00
Book Value per Share
(BPS, yen)
 1,206.19 1,262.78 1,307.93 1,511.83 1,557.72
Payout ratio (Consolidated)
（%）
 - 21.0 24.0 21.6 57.9
Cash flows from operating activities
(Millions of yen)
 -498 -230 340 330 594
Cash flows from investing activities
(Millions of yen)
 -2 -160 431 3,948 -584
Cash flows from financing activities
(Millions of yen)
 -374 569 -984 -2,273 -530
Cash and cash equivalents at end of period
(Millions of yen)
 2,026 2,276 2,118 4,240 3,774
Capital expenditures
(Millions of yen)
 235 455 471 996 567
Depreciation and Amortization
(Millions of yen)
 798 543 576 631 714
R&D expenses
(Millions of yen)
 1,176 1,298 1,076 926 1,011